Abstract:Purpose The aim of this study was to assess the potential of machine learning with multiparametric magnetic resonance imaging (mpMRI) for the early prediction of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) and of survival outcomes in breast cancer patients. Materials and Methods This institutional review board–approved prospective study included 38 women (median age, 46.5 years; range, 25–70 years) with breast cancer who were scheduled for NAC and underwent mpMRI of the breast at 3 T with dynamic contrast-enhanced (DCE), diffusion-weighted imaging (DWI), and T2-weighted imaging before and after 2 cycles of NAC. For each lesion, 23 features were extracted: qualitative T2-weighted and DCE-MRI features according to BI-RADS (Breast Imaging Reporting and Data System), quantitative pharmacokinetic DCE features (mean plasma flow, volume distribution, mean transit time), and DWI apparent diffusion coefficient (ADC) values. To apply machine learning to mpMRI, 8 classifiers including linear support vector machine, linear discriminant analysis, logistic regression, random forests, stochastic gradient descent, decision tree, adaptive boosting, and extreme gradient boosting (XGBoost) were used to rank the features. Histopathologic residual cancer burden (RCB) class (with RCB 0 being a pCR), recurrence-free survival (RFS), and disease-specific survival (DSS) were used as the standards of reference. Classification accuracy with area under the receiving operating characteristic curve (AUC) was assessed using all the extracted qualitative and quantitative features for pCR as defined by RCB class, RFS, and DSS using recursive feature elimination. To overcome overfitting, 4-fold cross-validation was used. Results Machine learning with mpMRI achieved stable performance as shown by mean classification accuracies for the prediction of RCB class (AUC, 0.86) and DSS (AUC, 0.92) based on XGBoost and the prediction of RFS (AUC, 0.83) with logistic regression. The XGBoost classifier achieved the most stable performance with high accuracies compared with other classifiers. The most relevant features for the prediction of RCB class were as follows: changes in lesion size, complete pattern of shrinkage, and mean transit time on DCE-MRI; minimum ADC on DWI; and peritumoral edema on T2-weighted imaging. The most relevant features for prediction of RFS were as follows: volume distribution, mean plasma flow, and mean transit time; DCE-MRI lesion size; minimum, maximum, and mean ADC with DWI. The most relevant features for prediction of DSS were as follows: lesion size, volume distribution, and mean plasma flow on DCE-MRI, and maximum ADC with DWI. Conclusions Machine learning with mpMRI of the breast enables early prediction of pCR to NAC as well as survival outcomes in breast cancer patients with high accuracy and thus may provide valuable predictive information to guide treatment decisions.

Factors associated with the local control of brain metastases: a systematic search and machine learning application

Predicting local control of brain metastases after stereotactic radiotherapy with clinical, radiomics and deep learning features

Prediction of the treatment response and local failure of patients with brain metastasis treated with stereotactic radiosurgery using machine learning: A systematic review and meta-analysis

Machine-Learning-Aided Prediction of Brain Metastases Development in Non-Small-Cell Lung Cancers

Comparative analysis of the spatial distribution of brain metastases across several primary cancers using machine learning and deep learning models

Prediction of treatment response in patients with brain metastasis receiving stereotactic radiosurgery based on pre-treatment multimodal MRI radiomics and clinical risk factors: A machine learning model

Abstract 63: Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits

Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients

Machine Learning in Metastatic Cancer Research: Potentials, Possibilities, and Prospects

Deep learning-based detection and quantification of brain metastases on black-blood imaging can provide treatment suggestions: a clinical cohort study

Potential of radiomics analysis and machine learning for predicting brain metastasis in newly diagnosed lung cancer patients

BrainMetDetect: Predicting Primary Tumor from Brain Metastasis MRI Data Using Radiomic Features and Machine Learning Algorithms

AI‐guided histopathology predicts brain metastasis in lung cancer patients

Dose-Incorporated Deep Ensemble Learning for Improving Brain Metastasis SRS Outcome Prediction

Development of an optimized machine learning approach to enhance brain metastatic burden assessment in preclinical models.

Machine Learning Leukemia clinical outcome prediction

1229 Leveraging Machine Learning for Pre-operative Prediction of Supralesional Ablation in Laser Interstitial Thermal Therapy (LITT) for Brain Tumors

Development of an optimized machine learning approach for assessing brain metastatic burden in preclinical models

Machine Learning-Based Algorithms for Enhanced Prediction of Local Recurrence and Metastasis in Low Rectal Adenocarcinoma Using Imaging, Surgical, and Pathological Data

Metastatic vs. Localized Disease As Inclusion Criteria That Can Be Automatically Extracted From Randomized Controlled Trials Using Natural Language Processing

Novel models by machine learning to predict prognosis of breast cancer brain metastases